Lead Discovery Center Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
72
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Lead Discovery Center General Information
Description
Operator of a translational drug research company intended to facilitate the translation of world-class science into innovative therapies for the benefits for patients. The company is an important link between academic research and industry, enabling scientific expertise to convert research results into drug candidates for pharmaceutical research.
Contact Information
Website
www.lead-discovery.deCorporate Office
- Otto-Hahn-Straße 15
- 44227 Dortmund
- Germany
Corporate Office
- Otto-Hahn-Straße 15
- 44227 Dortmund
- Germany
Lead Discovery Center Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Lead Discovery Center Patents
Lead Discovery Center Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4763280-A1 | Pharmaceutically active pyrazolo[5,1-c][1,4]benzoxazepine derivatives | Pending | 19-Dec-2024 | ||
| WO-2026132141-A1 | Pharmaceutically active pyrazolo[5,1-c][1,4]benzoxazepine derivatives | Pending | 19-Dec-2024 | ||
| WO-2026125705-A2 | Inhibitory antibodies of cytokine interleukin 11 dependent signaling pathways | Pending | 12-Dec-2024 | ||
| WO-2026125705-A3 | Inhibitory antibodies of cytokine interleukin 11 dependent signaling pathways | Pending | 12-Dec-2024 | ||
| US-20260217703-A1 | Inhibitors of a-hemol ysin of staphylococcus aureus | Pending | 21-Dec-2022 | C07D471/04 |
Lead Discovery Center Signals
Lead Discovery Center Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Matwin | Accelerator/Incubator |
Lead Discovery Center Investments (5)
Lead Discovery Center’s most recent deal was a Seed Round with EvlaBio for . The deal was made on 07-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| EvlaBio | 07-Jul-2025 | Seed Round | Drug Discovery | ||
| UGISense | 29-Apr-2021 | Later Stage VC | Drug Discovery | ||
| QLi5 Therapeutics | 16-Jan-2020 | Joint Venture | Drug Discovery | ||
| UGISense | 12-Oct-2016 | Corporate | Drug Discovery | ||
| Hit Discovery Constance | 01-Jan-2013 | Joint Venture | Other Pharmaceuticals and Biotechnology |
Lead Discovery Center Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| PearlRiver Bio | Dortmund, Germany | 2019 |
Lead Discovery Center FAQs
-
When was Lead Discovery Center founded?
Lead Discovery Center was founded in 2008.
-
Where is Lead Discovery Center headquartered?
Lead Discovery Center is headquartered in Dortmund, Germany.
-
What is the size of Lead Discovery Center?
Lead Discovery Center has 72 total employees.
-
What industry is Lead Discovery Center in?
Lead Discovery Center’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Lead Discovery Center a private or public company?
Lead Discovery Center is a Private company.
-
What is Lead Discovery Center’s current revenue?
The current revenue for Lead Discovery Center is .
-
Who are Lead Discovery Center’s investors?
Matwin has invested in Lead Discovery Center.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process